1 |
KURLAND G, MICHELSON P. Bronchiolitis obliterans in children[J].Pediatr Pulmonol,2005,39(3): 193-208.
|
2 |
MAUAD T, DOLHNIKOFF M, GROUP S P B O S. Histology of childhood bronchiolitis obliterans[J]. Pediatr Pulmonol, 2002, 33(6): 466-474.
|
3 |
COLOM A J, TEPER A M. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children[J]. Pediatr Pulmonol,2009,44(11):1065-1069.
|
4 |
TEPER A, FISCHER G B, JONES M H. Respiratory sequelae of viral diseases: from diagnosis to treatment[J]. J Pediatr (Rio J), 2002, 78(): S187-S194.
|
5 |
YOON H M, LEE J S, HWANG J Y, et al. Post-infectious bronchiolitis obliterans in children: CT features that predict responsiveness to pulse methylprednisolone[J]. Br J Radiol, 2015, 88(1049): 20140478.
|
6 |
MOONNUMAKAL S P, FAN L L. Bronchiolitis obliterans in children[J].Curr Opin Pediatr,2008,20(3): 272-278.
|
7 |
KONEN E, GUTIERREZ C, CHAPARRO C, et al. Bronchiolitis obliterans syndrome in lung transplant recipients: can thin-section CT findings predict disease before its clinical appearance? [J]. Radiology, 2004, 231(2): 467-473.
|
8 |
刘雪茹, 王艳丽, 陈和斌, 等. 儿童感染后闭塞性细支气管炎临床分析[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(5): 597-601.
|
9 |
GERHARDT S G, MCDYER J F, GIRGIS R E,et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study[J]. Am J Respir Crit Care Med, 2003, 168(1): 121-125.
|
10 |
TOMIKAWA S O, ADDE F V, SILVA FILHO L V R FDA, et al. Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy[J]. Orphanet J Rare Dis, 2014, 9: 128.
|
11 |
MOSQUERA R A, HASHMI S S, PACHECO S E, et al. Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliterans[J]. Clin Respir J, 2014, 8(1): 63-71.
|
12 |
中华医学会儿科学分会呼吸学组. 儿童闭塞性细支气管炎的诊断与治疗建议[J].中华儿科杂志,2012,50(10): 743-745.
|
13 |
TANOU K, XAIDARA A, KADITIS A G. Efficacy of pulse methylprednisolone in a pediatric case of postinfectious bronchiolitis obliterans[J]. Pediatr Pulmonol, 2015, 50(5): E13-E16.
|
14 |
陈晓雯, 吴上志, 谢 娜, 等. 抗中性粒细胞胞浆抗体在儿童闭塞性细支气管炎中的临床意义[J]. 国际呼吸杂志, 2021, 41(9): 655-659.
|
15 |
吴琳琳, 黄 晗, 沈照波, 等. 儿童闭塞性细支气管炎支气管肺泡灌洗液基质金属蛋白酶9、抗菌肽37、中性粒细胞与气道炎症程度的关系[J].安徽医药,2021,25(3):520-523.
|
16 |
JERKIC S P, KOC-GÜNEL S, HERRMANN E,et al. Long-term course of bronchial inflammation and pulmonary function testing in children with postinfectious bronchiolitis obliterans[J].Pediatr Pulmonol,2021,56(9):2966-2972.
|
17 |
VERLEDEN G M, VANAUDENAERDE B M, DUPONT L J, et al. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome[J]. Am J Respir Crit Care Med, 2006, 174(5): 566-570.
|
18 |
VOS R, VANAUDENAERDE B M, VERLEDEN S E,et al.Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection[J]. Transplantation, 2012, 94(2): 101-109.
|
19 |
ECKRICH J, HERRMANN E, VOSS S, et al. Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans[J]. Lung, 2016, 194(4): 571-579.
|
20 |
GAN C T J, WARD C, MEACHERY G, et al. Long-term effect of azithromycin in bronchiolitis obliterans syndrome[J]. BMJ Open Respir Res, 2019, 6(1): e000465.
|
21 |
林继雷, 郑雪香, 钟林平, 等. 小剂量阿奇霉素辅助治疗儿童闭塞性细支气管炎临床疗效分析[J]. 儿科药学杂志, 2019, 25(1): 18-20.
|
22 |
LI Y N, LIU L, QIAO H M, et al. Post-infectious bronchiolitis obliterans in children: a review of 42 cases[J]. BMC Pediatr, 2014, 14: 238.
|
23 |
MOONNUMAKAL S P, FAN L L.Bronchiolitis obliterans in children[J]. Curr Opin Pediatr,2008,20(3):272-278.
|
24 |
IZUMO T, KONDO M, NAGAI A. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice[J]. Life Sci, 2007, 80(20): 1882-1886.
|
25 |
VERLEDEN G M, VERLEDEN S E, VOS R, et al. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study[J]. Transpl Int, 2011, 24(7): 651-656.
|
26 |
RUTTEN S D, VERLEDEN S E, DEMEYER H, et al. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a randomized controlled trial[J]. PLoS One, 2018, 13(4): e0193564.
|
27 |
WILLIAMS K M, CHENG G S, PUSIC I, et al. Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation[J]. Biol Blood Marrow Transplant, 2016, 22(4): 710-716.
|
28 |
VOS R, EYNDE R V, RUTTENS D, et al. Montelukast in chronic lung allograft dysfunction after lung transplantation[J]. J Heart Lung Transplant, 2019, 38(5): 516-527.
|
29 |
JIMENEZ A, DE JESÚS-ROJAS W. Mycoplasma pneumoniae and bronchiolitis obliterans: how a common organism leads to a rare pulmonary disease in pediatrics[J]. Cureus, 2021, 13(8): e17193.
|
30 |
CHEN X, SHU J H, HUANG Y, et al. Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children[J]. Exp Ther Med, 2020, 20(3): 2649-2656.
|
31 |
MATTIELLO R, VIDAL P C, SARRIA E E, et al. Evaluating bronchodilator response in pediatric patients with post-infectious bronchiolitis obliterans: use of different criteria for identifying airway reversibility[J]. J Bras Pneumol, 2016, 42(3): 174-178.
|
32 |
KIM J, KIM M J, SOL I S, et al. Quantitative CT and pulmonary function in children with post-infectious bronchiolitis obliterans[J]. PLoS One, 2019, 14(4): e0214647.
|
33 |
ONAY Z R, RAMASLI GURSOY T, ASLAN A T, et al. Postinfectious bronchiolitis obliterans masked by misdiagnosis as asthma[J]. Pediatr Pulmonol, 2020, 55(4): 1007-1011.
|
34 |
ZHANG X M, LU A Z, YANG H W, et al. Clinical features of postinfectious bronchiolitis obliterans in children undergoing long-term nebulization treatment[J]. World J Pediatr, 2018, 14(5): 498-503.
|
35 |
TEIXEIRA M F C, RODRIGUES J C, LEONE C, et al. Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children[J]. Chest, 2013, 144(3): 974-980.
|
36 |
PELLEGRINO R, VIEGI G, BRUSASCO V, et al. Interpretative strategies for lung function tests[J]. Eur Respir J, 2005, 26(5): 948-968.
|
37 |
PARDO-SAGANTA A, LAW B M, TATA P R,et al. Injury induces direct lineage segregation of functionally distinct airway basal stem/progenitor cell subpopulations[J]. Cell Stem Cell, 2015, 16(2): 184-197.
|
38 |
MATTHAY M A, CALFEE C S, ZHUO H J, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial[J]. Lancet Respir Med, 2019, 7(2): 154-162.
|
39 |
LIN J L, DENG H R, ZHANG Y, et al. Effect of human umbilical cord-derived mesenchymal stem cells on murine model of bronchiolitis obliterans like injury[J]. Pediatr Pulmonol, 2021, 56(1): 129-137.
|
40 |
LIU S Y, YUAN M, HOU K D, et al. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells[J]. Cell Immunol, 2012, 278(1/2): 35-44.
|
41 |
LESAGE F, THÉBAUD B. Nanotherapies for micropreemies: stem cells and the secretome in bronchopulmonary dysplasia[J]. Semin Perinatol, 2018, 42(7): 453-458.
|
42 |
ARIS R M, WALSH S, CHALERMSKULRAT W, et al. Growth factor upregulation during obliterative bronchiolitis in the mouse model[J]. Am J Respir Crit Care Med, 2002, 166(3): 417-422.
|
43 |
COOKE K R, HILL G R, GERBITZ A, et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation[J].Transplantation,2000,70(2): 272-279.
|
44 |
FULLMER J J, FAN L L, DISHOP M K, et al. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade[J]. Pediatrics, 2005, 116(3): 767-770.
|
45 |
BOSA V L, MELLO E D, MOCELIN H T, et al. Assessment of nutritional status in children and adolescents with post-infectious bronchiolitis obliterans[J]. J Pediatr (Rio J), 2008, 84(4): 323-330.
|
46 |
FAUROUX B, PIGEOT J, POLKEY M I, et al. In vivo physiologic comparison of two ventilators used for domiciliary ventilation in children with cystic fibrosis[J]. Crit Care Med, 2001, 29(11): 2097-2105.
|
47 |
UYAN Z S, TURAN I, AY P, et al. Sleep disordered breathing and sleep quality in children with bronchiolitis obliterans[J]. Pediatr Pulmonol, 2016, 51(3): 308-315.
|
48 |
JERKIC S P, BRINKMANN F, CALDER A, et al. Postinfectious bronchiolitis obliterans in children: diagnostic workup and therapeutic options: a workshop report[J]. Can Respir J, 2020, 2020: 5852827.
|
49 |
钟永兴, 卢美萍, 陈志敏, 等. 儿童闭塞性细支气管炎特征及支气管肺泡灌洗[J]. 中华急诊医学杂志, 2010, 19(11): 1188-1192.
|
50 |
吴小英, 罗征秀, 符 州, 等. 儿童闭塞性细支气管炎28例临床分析[J]. 中国当代儿科杂志, 2013, 15(10): 845-849.
|
51 |
王敏茹. 肺部理疗辅助治疗小儿肺炎临床体会[J]. 内蒙古中医药, 2013, 32(9): 39-40.
|
52 |
CALABRESE C, CORCIONE N, REA G, et al. Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans[J]. J Bras Pneumol, 2016, 42(3): 228-231.
|
53 |
COLOM A J, MAFFEY A, GARCIA BOURNISSEN F, et al. Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up[J]. Thorax, 2015, 70(2): 169-174.
|
54 |
蒋华驰, 刘 峰, 郑明峰, 等. 再次肺移植治疗肺移植术后闭塞性细支气管炎综合征[J]. 中华移植杂志(电子版), 2017, 11(4): 221-224.
|